Denali Corp - DNLI Market Value
Denali Therapeutics (DNLI) relies on exclusive blood-brain barrier penetration technology, creating a significant gap between the company and its competitors. The asset value tracked on the GURU.Markets chart, which currently stands at 3.00, confirms the success of executives in attracting investment from global industry leaders. A stable top management team and partner confidence guarantee the reliable development of promising scientific research.
DNLI (Denali Corp): analytical breakdowns and indicator data
- market price and analyst price targets:
- issuer market value details:
- book value of equity indicators:
- business debt structure and liquidity details:
Total Debt to Capital Denali Therapeutics|DNLI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Denali Therapeutics|DNLI - Company Aggregate Debts|Debt to Book Capitalization Ratio Denali Corp|DNLI - Company Long-Term Loans and Borrowings|Company Short-Term Debt Denali Therapeutics|Quick Ratio denalitherapeutics.com
- financial results and valuation multiples details:
DNLI - Company Profit|Projected Future Earnings Denali Therapeutics|DNLI - Market Cap to Earnings|Future Price to Earnings Denali Therapeutics Inc|DNLI - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Denali Corp|DNLI - Operating profit EBITDA|Earnings per share for the last twelve months Denali Therapeutics|DNLI - Earnings per share for the last twelve months|Quarterly EPS earnings growth denalitherapeutics.com|DNLI - Expected net earnings per share growth this year|Expected earnings per share growth for next year Denali Therapeutics
- sales volume and revenue indicators:
Fundamental company analysis:DNLI (Denali Therapeutics Inc.)
Market capitalization separates the fundamental value of assets from short-term price fluctuations, measuring the total volume of equity through the lens of current demand and liquidity. By analyzing the history of the company's market valuation, an investor views capitalization as the market's recognition of the uniqueness of the blood-brain barrier crossing platform, which establishes Denali Therapeutics (DNLI) as a strategic leader in the therapy of neurodegenerative diseases.
Key competitors
Market Value Biogen BIIB|NBIX: Market Capitalization|RGC - Market Value|AXSM: Market Value|ACAD: Market Capitalization|XENE - Market Capitalization|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|HRMY - Market Value|Biohaven Ltd. - Market Valuation|Market Capitalization amylyx.com AMLX|TRVI - Market Value|Market Value PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Market Value|Market Value CeriBell EEG (CBLL)|PRTA (Prothena Corporation PLC) - Market Capitalization|Market Capitalization ALEC (Alector Therapeutics)|Market Capitalization ANNX|OMER - Market Value|Market Value Neurogene Corp NGNE|ACIU: Market Capitalization|Voyager Therapeutics - Market Capitalization|NMRA - Market Capitalization|Scilex (SCLX) - Market Value|TVGN (Tevogen Bio Holdings Inc.) - Market Value|ACOG (Alpha Cognition Inc) - Market Capitalization|cogrx.com (CGTX) - Market Capitalization|Market Valuation IKT (Inhibikase Therapeutics)|SAVA (cassavasciences.com) - Market Value|Assertio - Market Valuation|Market Value COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - Market Capitalization|Market Value OVID (Ovid Therapeutics Inc.)|ABOS: Market Capitalization|Market Value cervomed.com (CRVO)|Market Value Alterity Therapeutics Ltd.|CLNN: Market Value|Market Capitalization PEPG|Market Capitalization jupiterneurosciences.com (JUNS)|Market Value Relmada Therapeutics RLMD|ANVS (annovisbio.com) - Market Valuation|Grace Tx - Market Capitalization|Market Value Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Market Valuation|NeuroSense Therapeutics Ltd. (NRSN) - Market Capitalization|Market Valuation RVPH|MTVA (MetaVia, Inc.) - Market Value|Market Capitalization NRXS|Market Capitalization heliusmedical.com|Market Capitalization PASG (Passage Bio)|NEUP - Market Valuation|NERV - Market Value|Market Capitalization athira.com ATHA|ADXN: Market Capitalization|Market Capitalization ALZN|Market Value Cyclerion Therapeutics Inc.|Market Capitalization PTIX (Protagenic)|Market Value Pasithea Therapeutics (KTTA)|Market Value CRGT (cortigent.com)|Market Capitalization ATXI (Avenue Therapeutics, Inc.)|Market Capitalization Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Market Value|CHRO (Chromocell) - Market Capitalization|ELYM: Market Capitalization|Market Value Intra-Cellular Therapies, Inc. (ITCI)|Market Valuation LBPH|Market Capitalization Marinus Pharmaceuticals Inc|Market Value NKGen (NKGN)|NRBO (NeuroBo Pharma) - Market Value|Market Value Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Market Value|Trevena - Market Capitalization|VIGL (Vigil Neuroscience) - Market Capitalization|WENA: Market Capitalization|Market Value Cerevel Corp (CERE)
